JoseG.MontoyaMDFACP, FIDSA(He/Him)

PubMed

• 3 citations
  A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes ...
  Pablo C Okhuysen, Mayur S Ramesh, Thomas Louie, Nino Kiknadze, Julian Torre-Cisneros
  Clinical Infectious Diseases. 2024-06-14
• In defense of children's brain: reshuffling the laboratory toolbox for the diagnosis of congenital toxoplasmosis.
  Jose G Montoya
  Journal of Clinical Microbiology. 2024-06-12
• The Meat of the Matter.
  David Rutenberg, Yumeng Zhang, Jose G Montoya, John Sinnott, Despina G Contopoulos-Ioannidis
  The New England Journal of Medicine. 2024-05-02

Journal Articles

• Insights into Myalgic encephalomyelitis/chronic Fatigue Syndrome Phenotypes Through Comprehensive Metabolomics  
  Lucinda Bateman, Jose G. Montoya, Mady Hornig, Nancy G. Klimas, Nature
• Genetic Characterization of Toxoplama Gondii DNA Samples Isolated from Humans Living in North America: An Unexpected High Prevalence of Atypical Genotypes  
  Jose Montoya, MD, The Journal of Infectious Diseases
• Deconstructing Post-Exertional Malaise in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: A Patient-Centered, Cross-Sectional Survey  
  Jose Montoya, MD, PLoS One
• Toxoplasma gondii Infection in the United States, 2011-2014  
  Jones JL, Kruszon-Moran D, Elder S, Rivera HN, Press C, Montoya JG, McQuillan GM, American Journal of Tropical Medicine and Hygiene, 1/1/2018
• Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with chronic fatigue syndrome  
  Zinn MA, Zinn ML, Valencia I, Jason LA, Montoya JG, Biological Psychology, 1/1/2018
• Prevention and treatment of cytomegalovirus in immunocompromised patients: beyond DNA polymerase inhibition  
  Montoya JG, Gomez CA, Lee R, Current Opinion in Infectious Diseases, 1/1/2018
• Prevention of infectious diseases in patients with Good syndrome  
  Multani A, Gomez CA, Montoya JG, Current Opinion in Infectious Diseases, 1/1/2018
• Toxoplasmosis in the non-orthotopic heart transplant recipient population, how common is it? Any indication for prophylaxis?  
  Dhakal R, Gajurel K, Montoya JG, Current Opinion in Organ Transplantation, 1/1/2018
• KPAX002 as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a prospective, randomized trial  
  Montoya JG, Anderson JN, Adolphs DL, Bateman L, Klimas N, Levine SM, Garvert DW, Kaiser JD, International Journal of Clinical and Experimental Medicine, 1/1/2018
• Symptomatic Acute Toxoplasmosis in Returning Travelers  
  Henao-Martinez AF, Franco-Paredes C, Palestine AG, Montoya JG, Open Forum Infectious Diseases, 1/1/2018
• Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey  
  Chu L, Valencia IJ, Garvert DW, Montoya JG, PLoS One, 1/1/2018
• Value of Circulating Cytokine Profiling During Submaximal Exercise Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome  
  Moneghetti KJ, Skhiri M, Contrepois K, Kobayashi Y, Maecker H, Davis M, Snyder M, Haddad F, Montoya JG, Scientific Reports, 1/1/2018
• Upregulation of HERV-K is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension  
  Saito T, Miyagawa K, Chen SY, Tamosiuniene R, Wang L, Sharp O, Samayoa E, Harada D, Moonen JAJ, Cao A, Chen PI, Hennigs JK, Gu M, Li CG, Leib RD, Li D, Adams CM, Del R..., Circulation, 1/1/2017
• Donor-derived infections in solid organ transplant patients: toward a holistic approach  
  Benamu E, Wolfe CR, Montoya JG, Current Opinion in Infectious Diseases, 1/1/2017
• Validation of IgG, IgM multiplex plasmonic gold platform in French clinical cohorts for the serodiagnosis and follow-up of Toxoplasma gondii infection  
  Pomares C, Zhang B, Arulkumar S, Gonfrier G, Marty P, Zhao S, Cheng S, Tang M, Dai H, Montoya JG, Diagnostic Microbiology and Infect Disease, 1/1/2017
• Patients diagnosed with myalgic encephalomyelitis/ chronic fatigue syndrome also fit systemic exertion intolerance disease  
  Chu L, Norris JL, Valencia IJ, Montoya JG, Fatigue: Biomedicine, Health, and Behavior, 1/1/2017
• Survivorship, Version 22017, NCCN Clinical Practice Guidelines in Oncology  
  Denlinger CS, Sanft T, Baker KS, Baxi S, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Hudson M, Khakpour N, King A, Koura D, Kvale E, Lally RM, Langbaum T..., Journal of the National Comprehensive Cancer Network, 1/1/2017
• Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/ chronic fatigue syndrome  
  Nagy-Szakal D, Williams BL, Mishra N, Che X, Lee B, Bateman L, Klimas NG, Komaroff AL, Levine S, Montoya JG, Peterson D, Ramanan D, Jain K, Eddy ML, Hornig M, Lipkin WI, Microbiome, 1/1/2017
• Committee On Infectious Diseases  
  Maldonado YA, Read JS, Pediatrics, 1/1/2017
• Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries  
  Begeman IJ, Lykins J, Zhou Y, Lai BS, Levigne P, El Bissati K, Boyer K, Withers S, Clouser F, Noble AG, Rabiah P, Swisher CN, Heydemann PT, Contopoulos-Ioannidis DG, M..., PLoS Neglected Tropical Diseases, 1/1/2017
• Congenital Toxoplasmosis in France and the United States: One Parasite, Two Diverging Approaches  
  Peyron F, Mc Leod R, Ajzenberg D, Contopoulos-Ioannidis D, Kieffer F, Mandelbrot L, Sibley LD, Pelloux H, Villena I, Wallon M, Montoya JG, PLoS Neglected Tropical Diseases, 1/1/2017
• A Novel Cytokine Signature Associated with Disease Severity in Chronic Fatigue Syndrome Patients  
  Montoya JG, Holmes TH, Anderson JA, Maecker HT, PhD, Rosenberg-Hasson Y, Younger JW, Valencia I, MS, Chu L, Tato CM, Davis MM, PNAS, 1/1/2017
• Reply to Roerink et al: Methods for recruitment, serum separation, and storage were the same for patients and controls  
  Montoya JG, Maecker HT, Rosenberg-Hasson Y, Davis MM, PNAS, 1/1/2017
• Toxoplasmosis in hematopoietic cell transplant recipients  
  Gajurel K, Dhakal R, Montoya JG, Transplant Infectious Disease, 1/1/2017
• Lifelong Persistence of Toxoplasma Cysts: A Questionable Dogma?  
  Rougier S, Montoya JG, Peyron F, Trends in Parasitology, 1/1/2017
• Join now to see all

Books/Book Chapters

• Transplant Infections. 
  Chapter: Toxoplasmosis in Solid Organ Transplant Patients 
  Montoya JG, Gomez CAEditors: Bowden RA, Ljungman P, and Snydman DR.Lippincott Williams & Wilkins, Philadelphia, PAEdition 4th,2016
• Section 3, Summaries of Infectious Diseases; 2015 Red Book 
  Chapter: Toxoplasma gondii Infections 
  Montoya JG, Boyer, KEditors: D. Kimberlin.2015
• Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 
  Chapter: Toxoplasma gondii 
  Page 3122 - 3153Montoya JG, Boothroyd J, Kovacs JEditors: Bennett J.E., Dolin R. and Blaser, MJ.Elsevier Churchill LivingstoneEdition 8th,2015
• Human Herpesviruses HHV-6A, HHV-6B & HHV-7 
  Chapter: Treating HHV-6 Infections: Laboratory Efficacy and Clinical Use of Anti-HHV-6 Agents 
  Pritchett JC, Naesens L, Montoya, JGEditors: Flamand L, Lautenschlager I, Krueger G, Ablashi D.ElsevierEdition 3rd,2014
• Infections of the Central Nervous System 
  Chapter: Toxoplasma gondii and Toxoplasmosis 
  Montoya JGEditors: Michael Scheld, Richard Whitley, and Christina Marra.Wolters Kluwer Health, Philadelphia, PAEdition 4th,2014
• Principles and Practice of Pediatric Infectious Diseases. 
  Chapter: Toxoplasma gondii Infection an Toxoplasmosis 
  Page 1307 - 1308Contopoulos D., Montoya, JGElsevier SaundersEdition 4th,2012
• Sande�s HIV/AIDS Medicine: Medical Management of AIDS 2013. 
  Chapter: Toxoplasma gondii and Toxoplasmosis. 
  Page 397 - 410Moncada P, Montoya. JGEditors: Volberding PA, Greene WC, Lange JMA, Gallant JE, Sewankambo N.Elsevier SaundersEdition 2nd,2012
• Goldman�s Cecil Medicine. 
  Chapter: Toxoplasmosis. 
  Page 2030 - 2038Montoya J.G.Editors: Goldman L and Schafer AI.Elsevier Saunders, Philadelphia, PAEdition 24th,2012
• Red Book: 2012 Report of the Committee on Infectious Diseases. 
  Chapter: Toxoplasma gondii Infections (Toxoplasmosis) 
  Page 720 - 728Montoya, JG, Boyer, K. American Academy of PediatricsEditors: Pickering LK, Baker CJ, Kimberlin DW, Long SS.American Academy of Pediatrics, Elk Grove Village, ILEdition 29th,2012
• Principles and Practice of Cancer Infectious Diseases. 
  Chapter: Parasitic Infections in Cancer Patients: Toxoplasmosis, Strongyloidiasis, and Other Parasites 
  Blackburn B, Montoya JGEditors: Safdar, A.Humana Press, New York, NYEdition 1st,2011
• Principles and Practice of Infectious Diseases. 
  Chapter: Toxoplasma gondii 
  Page 3495 - 3526Montoya JG, Boothroyd J, Kovacs JEditors: Mandell G, Dolin A, Bennett J.Elsevier Churchill LivingstoneEdition 7th,2010
• Infection in Solid Organ Transplant Patients. 
  Chapter: Toxoplasmosis in Transplant Patients 
  Montoya JGEditors: Nina Singh.2009
• Global HIV/AIDS Medicine 
  Chapter: AIDS-associated toxoplasmosis. 
  Page 399 - 413Subauste, C.S., Montoya JG. and J.S. RemingtonEditors: M.A. Sande, J. P. Lange, and P.A. Volberding.W.B. Saunders Co., Philadelphia, PA2008
• EMPIRIC Antimicrobial Therapy and Vaccines: Volume I: Microbes. 
  Chapter: Toxoplasma gondii 
  Montoya JGEditors: Yu VL, Weber R, Raoult D.ESun Technologies2008
• Principles and Practice of Infectious Diseases 
  Chapter: Toxoplasma gondii 
  Page 3170 - 3198Montoya JG, Remington, JSEditors: Mandell G, Dolin A, Bennett J.Elsevier Churchill Livingstone, Philadelphia, PAEdition 6th,2005
• Infectious Diseases Text & Website Package 
  Chapter: Infections in the Immunocompromised Host-Opportunistic Parasitic Infections. 
  Montoya JGEditors: J. Cohen, and W. G. Powderly.Elsevier Science Ltd., Edinburgh, United KingdomEdition 2nd,2003
• Conn's Current Therapy 2003. 
  Chapter: Toxoplasma gondii 
  Page 161 - 169Montoya JGEditors: Rakel RE, Bope ET.WB Saunders, Philadelphia, PA2003
• Current Diagnosis and Treatment in Infectious Diseases. 
  Chapter: Toxoplasma gondii. Chapter 81. 
  Page 807 - 816Montoya JGEditors: Wilson W, Sande M.Lange Medical Books, Mc Graw Hil, New York, NYEdition 1st,2001
• Current Diagnosis and Treatment in Infectious Diseases. 
  Chapter: Chlamydia. Chapter 67. 
  Page 694 - 702Montoya JGEditors: Wilson W, Sande M.Lange Medical Books, Mc Graw Hil, New York, NYEdition 1st,2001
• Current Diagnosis and Treatment in Infectious Diseases. 
  Chapter: Mycoplasma & Ureaplasma. Chapter 66. 
  Page 690 - 693Montoya JGEditors: Wilson W, Sande M.Lange Medical Books, Mc Graw Hil, New York, NYEdition 1st,2001
• Current Diagnosis and Treatment in Infectious Diseases. 
  Chapter: Hepatobiliary Infections. Chapter 21. 
  Page 269 - 286Eckburg PB, Montoya JGEditors: Wilson W, Sande M.Lange Medical Books, Mc Graw Hil, New York, NYEdition 1st,2001
• Current Diagnosis and Treatment in Infectious Diseases. 
  Chapter: Borrelia and Leptospira Species. Chapter 65. 
  Page 680 - 689Chaparro S, Montoya JGEditors: Wilson W, Sande M.Lange Medical Books, Mc Graw Hil, New York, NYEdition 1st,2001
• Texbook of AIDS Medicine. 
  Chapter: Tuberculosis 
  Page 261 - 284Shafer RW, Montoya JGEditors: Broder S, Merigan TC, Barlett JG.Williams and Wilkins, Media, PAEdition 2nd,1998
• In defense of the brain: current concepts in the immuno-pathogenesis and clinical aspects of CNS infections. 
  Chapter: Toxoplasmosis of the Central Nervous System. Chapter 10. 
  Page 163 - 188Montoya JG, Remington JSEditors: Peterson PK, Remington JS.Blackwell Science, Malden, MA1997
• Join now to see all

Abstracts/Posters

• Acanthamoeba Encephalitis in a Patient with a Total Artificial Heart (Syncardia Device)
  Gajurel K, Tan S, Banerjee D, Deresinski S, Montoya JG, Ha R, World Transplant Congress, San Francisco, CA, 1/26/2014
• Circulating Cytokines in Pregnant Women Infected with Toxoplasma gondii
  Montoya JG, Wallon M, Valencia I, Maecker HT, Rosenberg-Hasson Y, Peyron, F, Holmes TH, IDWeek, Philadelphia, PA, 1/8/2014
• Clinical and Echocardiographic Presentation of Rejection Episodes Following Heart Transplantation.
  Sudini, NL, Huo J, Pan S; Montoya, JG; Leon S, Vu T, Beygui RE, Vrtovec B, Wu JC, Pham M, Kush K, Berry G, Hunt S, Haddad F, 33rd Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation, Montreal, Canada, 1/24/2013
• Profiling immune response to Toxoplasma gondii infection reveals different cytokine patterns in American and Colombian patients.
  Pernas L., Ramirez R., Holmes T., Montoya JG, Boothroyd J. Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA; Palo Alto M..., 12th International Congress on Toxoplasmosis, St. Catherine�s College, Oxford University, Oxford, United Kingdom, 1/22/2013
• Elevated Right Ventricular Operant Diastolic Elastance Strongly Predicts Increased Risk of Mortality Following Heart Transplantation
  Rhee JW; Sudini NL; Pham M; Fearon W; Lee D; Beygui RE; Montoya JG; Wu JC; Vrtovec B; Hunt SA; Haddad F, Circulation; American Heart Association Scientific Sessions, Dallas, TX, 1/1/2013
• Invasive Aspergillosis -Associated Immune Reconstitution Syndrome In Lung Transplant Recipients (abstract #971)
  Singh N., Wagner M., Suarez J., Avery R., Lass Floerl C., Pasqualotto, 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1/9/2012
• Airway invasive pulmonary aspergillosis versus angioinvasive aspergillosis have distinct risk factors and outcomes in lung transplant recipients (abstract #972)
  Singh N., Wagner M., Suarez J., Avery R., Lass Floerl C., Pasqualotto A.C., Lyon G.M., Barron M., Husain S., Montoya J.G., U Pitt, Pitt, PA, Stanford, Palo Alto, CA, C..., 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1/9/2012
• Evaluation of the VIDAS (R) TOXO IgG Avidity Assay Compared to a Composite Reference Method (Palo Alto Medical Foundation Toxoplasma Serological Profile) as a Test to ...
  Montoya J.G., Press C., Munk G., Young, S., PhD4, Rice B.J., 49th IDSA Annual Meeting, Boston, MA, 1/20/2011
• Polymerase Chain Reaction in Cerebrospinal Fluid for Diagnosis of Congenital Toxoplasmosis
  Olariu T.R., Remington J.S., Montoya J.G., IV International Congress on Congenital Toxoplasmosis, Marseilles, France, 1/28/2010
• Severe Congenital Toxoplasmosis in the United States: Clinical and Serological Findings
  Olariu T.R., Remington J.S., McLeod R, Alam A., Montoya J.G., IV International Congress on Congenital Toxoplasmosis, Marseilles, France, 1/28/2010
• Congenital toxoplasmosis in the new world.
  Olariu T.R., Remington J.S., Montoya, J.G., IV International Congress on Congenital Toxoplasmosis, Marseilles, France, 1/28/2010
• Montoya, J.G., Press, C., Rice, B.J., American Society of Microbiology 110th Meeting, San Diego, CA, 1/23/2010
• Changing Trends in Infectious Complications among Heart Transplant Recipients.
  Haddad F, Deuse T, Rosso F, Pham M, Khazanie P, Luikart H, Valantine H, Hunt S, Reitz B, Robbins RC, Oyer PE, Montoya JG, ISHLT 29th Annual Meeting and Scientific Sessions, Palais de Congres, Paris, France, 1/22/2009
• Comparative evaluation of VIDIA and AXSYM toxoplasmosis reagents in a high prevalence Latin America Country.
  Weber B, Alvarez-Otero Y, Badiel M, Thulliez P, Montoya JG, 6th World Congress of the World Society for Pediatric Infectious Diseases, Buenos Aires, Argentina, 1/19/2009
• Comparative evaluation of VIDAS and AXSYM Toxoplasmosis reagents in a high seroprevalence Lain America Country.
  Weber B, Alvarez-Otero Y, Badiel M, Thulliez P, Montoya JG, 6th World Congress of the World Society for Pediatric Infectious Diseases, Buenos Aires, Argentina, 1/19/2009
• Risk Factors for Toxoplasma gondii infection in Cali, Colombia.
  Badiel M, Alvarez Y, Bisinger A, Telleria J, Rosso F, Tunubala G, Blackburn B, Montoya JG, 6th World Congress of the World Society for Pediatric Infectious Diseases, Buenos Aires, Argentina, 1/19/2009
• Role of Elevated Antibody Titers Against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) in Predicting Response to Valganciclovir in Patients with Chronic Fat...
  Kar AK, Bhangoo MS, Lunn MR, Kogelnik AM, Montoya JG, 6th International Conference on HHV-6 & 7, Baltimore, MD, 1/21/2008
• Antiviral Therapy Induces Viral and Clinical Response in Patients with Central Nervous System Dysfunction and Chromosomally Integrated Human Herpesvirus-6.
  Lunn MR, Neely MN, Ambros PF, Kar AK, Troy SB Montoya JG, 6th International Conference on HHV-6 & 7, Baltimore, MD, 1/21/2008
• A Randomized Double-Blind, Placebo-Controlled Trial on the Use of Valganciclovir in Patients with Chronic Fatigue Syndrom (CFS) and Elevated Herpesvirus-6 (HHV-6) and ...
  Bhangoo MS, Kogelnik AM, Lunn MR, Kar AK, DeGuzman ML, Montoya JG, 6th International Conference on HHV-6 & 7, Baltimore, MD, 1/21/2008
• Sources of Toxoplasma gondii infection in the United States.
  Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG, 57th ASTMH Annual Meeting, New Orleans, LA, 1/7/2008
• Use of Valganciclovir in Patients Chronically Co-infected with Human Herpes Virus 6 (HHV-6) and Epstein-Barr Virus (EBV) who were Experiencing Long-standing Fatigue: A...
  Kogelnik A, Rosso F.Hoegh-Petersen M, Montoya JG, 8th International IACFS Conference on Chronic Fatigue Syndrome, Fibromyalgia and other Related Illnesses, Fort Lauderdale, FL, 1/10/2007
• Use of Valganciclovir in Patients Chronically Co-infected with Human Herpes Virus 6 (HHV-6) and Epstein-Barr Virus (EBV) who were Experiencing Long-standing Fatigue
  Kogelnik A, Rosso F.Hoegh-Petersen M, Montoya JG, 5th International Conference on HHV-6&7, Barcelona, Spain, 1/30/2006
• Changing Trends in CMV Infection and Disease in Heart Transplant Patients
  Rosso F, Valantine H, Montoya JG, 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1/27/2006
• Does Infection (Other Than Cmv) Trigger Rejection In Heart Transplant Patients?
  Rosso F, Potena L, Holweg CTJ, Vana ML, Bashyam L, Rajamani J, McCormick L, Cooke JP, Hannah VA, Mocarski ES, Montoya JG, World Transplant Congress of the ASTS, TTS and the AST, Boston, MA, 1/22/2006
• Perception of pregnant women towards threat of congenital Toxoplasmosis infection in Cali, Colombia
  Rosso F, Les J, Montoya JG, International Conference on Women and Infectious Diseases: Progress in Science and Action, Atlanta, GA, 1/16/2006
• Join now to see all

Lectures

• Immune Suppressing Monoclonal Antibodies and Infections 
  Snowmass, CO - 1/26/2018
• New Tick-borne Infections in the United States. 
  Snowmass, CO - 1/26/2018
• Severe Infections in Pregnancy. 
  Snowmass, CO - 1/26/2018
• Citomegalovirus en Trasplantes de Organos. Lo nuevo en diagnostico y Tratamiento. 
  Bogota, Colombia - 1/24/2018
• Sindrome de fatiga cronica y virus. Cual es la conexion? 
  Bogota, Colombia - 1/24/2018
• Evaluation of three point-of-care (POC) tests for detection of Toxoplasma-IgG and IgM in the United States: proof of concept and pitfalls. 
  Madrid, Spain - 1/21/2018
• Genetic characterization of Toxoplasma gondii DNA samples isolated from humans living in North America: an unexpected high prevalence of atypical genotypes. 
  Madrid, Spain - 1/21/2018
• Laboratory Diagnosis of Toxoplasmosis: Present and Future. 
  Nice, France - 1/16/2018
• Chronic Fatigue Syndrome- Is It Treatable? 
  Sacramento, CA - 1/15/2017
• Toxoplasmosis: Update on Diagnosis and Treatment 
  Sacramento, CA - 1/15/2017
• ME/CFS: An Unfolding Story of Scientific Discoveries and Future Targeted Treatments. 
  Bristol, United Kingdom - 1/13/2017
• Circulating Cytokine Signatures Associated with ME/CFS Severity and Duration. Insights into the Immunology of Chronic Fatigue Syndrome Organized by the Division of All... 
  Chicago, IL - 1/12/2017
• Immune Reconstitution Inflammatory Syndrome (IRIS) in Non-HIV Patients: Recognition and Treatment. 
  Sun Valley, ID - 1/12/2017
• Immunizing Older Adults. 
  Sun Valley, ID - 1/12/2017
• The Clinical Spectrum of Toxoplasmosis. 
  Sun Valley, ID - 1/12/2017
• Invasive Fungal Infections in Hemato-Oncology Patients. 
  Barranquilla, Colombia - 1/9/2017
• Mold Infections in Transplanted Patients. 
  Barranquilla, Colombia - 1/9/2017
• Toxoplasmosis. 
  Barranquilla, Colombia - 1/9/2017
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Fact, Fiction, Findings 
  Atlanta, GA - 1/4/2017
• A Profile of Circulating Cytokines is Associated with Disease Severity in Chronic Fatigue Syndrome Patients (CFS) 
  Fort Lauderdale, FL - 1/27/2016
• Exercise testing highlights differences in cytokine profile and network between patients with chronic fatigue syndrome and healthy sedentary participants. 
  Fort Lauderdale, FL - 1/27/2016
• Genomics of chronic fatigue syndrome reveals systemic inflammatory response. 
  Fort Lauderdale, FL - 1/27/2016
• Post-exertional malaise: multiple and unexpected symptoms, sometimes delayed, often prolonged. 
  Fort Lauderdale, FL - 1/27/2016
• Right Arcuate Abnormality and Correlation with Serum Cytokines in CFS. 
  Fort Lauderdale, FL - 1/27/2016
• The Synergy Trial for CFS - A Phase 2 Study of Low-Dose Methylphenidate plus Mitochondrial Support in Patients with Chronic Fatigue Syndrome. 
  Fort Lauderdale, FL - 1/27/2016
• Join now to see all

Other

• Use of cephalosporins in adults. A drug class review. 
  Hosseini M, Montoya JG, Department of Pharmacy Drug Information Service Newsletter
  Stanford University Medical Center - 1/1/1998
• Blood cultures: a new Stanford Health Services protocol to improve procedures and practices used for diagnosis of bacteremia 
  Mickelsen P, Montoya JG, Smith K, Infectious Diseases Service Line Bulletin
  1/1/1996